<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-27">July 27, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elena</forename><surname>Vigorito</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karoline</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jonathan</forename><surname>Beesley</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<addrLine>Herston Road</addrLine>
									<postCode>4029</postCode>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julian</forename><surname>Adlard</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Yorkshire Regional Genetics Service</orgName>
								<orgName type="institution">Chapel Allerton Hospital</orgName>
								<address>
									<settlement>Leeds</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bjarni</forename><forename type="middle">A</forename><surname>Agnarsson</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University Hospital (Landspitali)</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">University of Iceland School of Medicine</orgName>
								<address>
									<postCode>101</postCode>
									<settlement>Hringbraut, Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Irene</forename><forename type="middle">L</forename><surname>Andrulis</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Lunenfeld-Tanenbaum Research Institute</orgName>
								<orgName type="institution" key="instit2">Mount Sinai Hospital</orgName>
								<address>
									<postCode>M5G 1X5</postCode>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Banu</forename><forename type="middle">K</forename><surname>Arun</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Breast Medical Oncology and Clinical Cancer Genetics Program</orgName>
								<orgName type="institution">University Of Texas MD Anderson Cancer Center</orgName>
								<address>
									<addrLine>1515 Pressler Street, CBP 5</addrLine>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>7 Bâtiment Cheney D</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">Centre Léon Bérard</orgName>
								<address>
									<addrLine>28 rue Laënnec</addrLine>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laure</forename><surname>Barjhoux</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Muriel</forename><surname>Belotti</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de Génétique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff89">
								<address>
									<postCode>00029 HUS</postCode>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Javier</forename><surname>Benitez</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Spanish National Cancer Centre (CNIO)</orgName>
								<orgName type="laboratory">Human Genetics Group</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Berger</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anders</forename><surname>Bojesen</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernardo</forename><surname>Bonanni</surname></persName>
							<affiliation key="aff16">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Genetics</orgName>
								<orgName type="department" key="dep2">Istituto Europeo di Oncologia (IEO)</orgName>
								<address>
									<addrLine>via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carole</forename><surname>Brewer</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Royal Devon &amp; Exeter Hospital</orgName>
								<address>
									<settlement>Exeter</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Trinidad</forename><surname>Caldes</surname></persName>
							<affiliation key="aff18">
								<orgName type="laboratory">Molecular Oncology Laboratory</orgName>
								<orgName type="institution" key="instit1">Hospital Clinico San Carlos</orgName>
								<orgName type="institution" key="instit2">IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)</orgName>
								<address>
									<addrLine>Martin Lagos s/n</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><forename type="middle">A</forename><surname>Caligo</surname></persName>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Section of Genetic Oncology</orgName>
								<orgName type="department" key="dep2">Dept. of Laboratory Medicine</orgName>
								<orgName type="department" key="dep3">16 Research Division</orgName>
								<orgName type="institution">University and University Hospital of Pisa</orgName>
								<address>
									<settlement>Pisa Italy</settlement>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="institution">Peter MacCallum Cancer Centre</orgName>
								<address>
									<addrLine>Locked Bag 1, A&apos;Beckett Street, 17 1600 Divisadero Street</addrLine>
									<postCode>8006, C415, 94143-1714</postCode>
									<settlement>Melbourne, San Francisco</settlement>
									<region>VIC, CA</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ian</forename><surname>Campbell</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Salina</forename><forename type="middle">B</forename><surname>Chan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kathleen</forename><forename type="middle">B M</forename><surname>Claes</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<addrLine>De Pintelaan 185</addrLine>
									<postCode>9000</postCode>
									<settlement>Gent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">E</forename><surname>Cohn</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Columbus Cancer Council GYN Oncology</orgName>
								<orgName type="institution">Ohio State University</orgName>
								<address>
									<addrLine>3651 Ridge Mill Drive</addrLine>
									<postCode>43026</postCode>
									<settlement>Columbus</settlement>
									<region>OH</region>
								</address>
							</affiliation>
							<affiliation key="aff24">
								<orgName type="department">Clinical Genetics Service</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>20 Sheffield</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="institution">Sheffield Children&apos;s Hospital</orgName>
								<address>
									<settlement>Sheffield</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jackie</forename><surname>Cook</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">B</forename><surname>Daly</surname></persName>
							<affiliation key="aff26">
								<orgName type="department" key="dep1">Department of Clinical Oncology</orgName>
								<orgName type="department" key="dep2">Fox Chase Cancer Center</orgName>
								<orgName type="department" key="dep3">Department of Clinical Genetics</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>333 Cottman Avenue</addrLine>
									<postCode>22</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff27">
								<orgName type="institution">South Glasgow University Hospitals</orgName>
								<address>
									<addrLine>23 Unité d&apos;oncogénétique</addrLine>
									<settlement>Glasgow</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff28">
								<orgName type="institution">ICO-Centre René Gauducheau</orgName>
								<address>
									<addrLine>Boulevard Jacques Monod</addrLine>
									<postCode>44805</postCode>
								</address>
							</affiliation>
							<affiliation key="aff29">
								<orgName type="institution">Nantes Saint Herblain Cedex</orgName>
								<address>
									<addrLine>24 Oncogenetics Group</addrLine>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff30">
								<orgName type="department">Vall d&apos;Hebron Institute of Oncology (VHIO)</orgName>
								<orgName type="institution" key="instit1">Vall d&apos;Hebron University Hospital</orgName>
								<orgName type="institution" key="instit2">Universitat Autònoma</orgName>
								<address>
									<addrLine>Passeig Vall d&apos;Hebron 119-129</addrLine>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesca</forename><surname>Damiola</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rosemarie</forename><surname>Davidson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Antoine</forename><surname>De Pauw</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de Génétique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff89">
								<address>
									<postCode>00029 HUS</postCode>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Capucine</forename><surname>Delnatte</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Orland</forename><surname>Diez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">M</forename><surname>Domchek</surname></persName>
							<affiliation key="aff31">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Abramson Cancer Center</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<addrLine>3400 Civic Center Boulevard</addrLine>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff32">
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>26 Genomics Center</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff33">
								<orgName type="institution" key="instit1">Centre Hospitalier Universitaire de Québec Research Center</orgName>
								<orgName type="institution" key="instit2">Laval University</orgName>
								<address>
									<addrLine>2705 Laurier Boulevard</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff34">
								<orgName type="institution">Quebec City (Quebec)</orgName>
								<address>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martine</forename><surname>Dumont</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Katarzyna</forename><surname>Durda</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<addrLine>Polabska 4</addrLine>
									<settlement>Szczecin</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernd</forename><surname>Dworniczak</surname></persName>
							<affiliation key="aff36">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Münster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Douglas</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><surname>Eccles</surname></persName>
							<affiliation key="aff37">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Southampton</orgName>
								<orgName type="institution" key="instit2">Southampton University Hospitals NHS Trust</orgName>
								<address>
									<settlement>Southampton</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christina</forename><forename type="middle">Edwinsdotter</forename><surname>Ardnor</surname></persName>
							<affiliation key="aff38">
								<orgName type="department">Department of Radiation Sciences, Oncology</orgName>
								<orgName type="institution">Umeå University</orgName>
								<address>
									<settlement>Umea</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ros</forename><surname>Eeles</surname></persName>
							<affiliation key="aff39">
								<orgName type="institution" key="instit1">Oncogenetics Team</orgName>
								<orgName type="institution" key="instit2">The Institute of Cancer Research and Royal Marsden NHS Foundation Trust</orgName>
								<address>
									<settlement>Sutton</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Steve</forename><surname>Ellis</surname></persName>
							<affiliation key="aff40">
								<orgName type="department">Department of Oncology, Rigshospitalet</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<addrLine>Blegdamsvej 9</addrLine>
									<postCode>DK-2100</postCode>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff41">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="laboratory">Strangeways Research Laboratory</orgName>
								<address>
									<addrLine>Worts Causeway</addrLine>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Gareth Evans</surname></persName>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Genomic Medicine</orgName>
								<orgName type="department" key="dep2">Institute of Human Development</orgName>
								<orgName type="institution" key="instit1">Manchester Academic Health Sciences Centre</orgName>
								<orgName type="institution" key="instit2">Manchester University</orgName>
								<address>
									<settlement>Central</settlement>
								</address>
							</affiliation>
							<affiliation key="aff44">
								<orgName type="institution">Manchester University Hospitals NHS Foundation Trust</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lidia</forename><surname>Feliubadalo</surname></persName>
							<affiliation key="aff45">
								<orgName type="institution">Molecular Diagnostic Unit</orgName>
								<address>
									<addrLine>Hereditary Cancer Program</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff46">
								<orgName type="institution" key="instit1">IDIBELL (Bellvitge Biomedical Research Institute)</orgName>
								<orgName type="institution" key="instit2">Catalan Institute of Oncology</orgName>
								<orgName type="institution" key="instit3">Gran Via de l&apos;Hospitalet</orgName>
								<address>
									<postCode>199-203, 08908 L&apos;</postCode>
									<settlement>Hospitalet, Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florentia</forename><surname>Fostira</surname></persName>
							<affiliation key="aff47">
								<orgName type="department">Institute of Nuclear and Radiological Sciences and Technology</orgName>
								<orgName type="laboratory">Molecular Diagnostics Laboratory</orgName>
								<orgName type="institution">National Centre for Scientific Research &quot;Demokritos&quot;</orgName>
								<address>
									<addrLine>Patriarchou Gregoriou &amp; Neapoleos str</addrLine>
									<settlement>Aghia Paraskevi, Attiki, Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">William</forename><forename type="middle">D</forename><surname>Foulkes</surname></persName>
							<affiliation key="aff48">
								<orgName type="department">Departments of Human Genetics and Oncology</orgName>
								<orgName type="laboratory">Program in Cancer Genetics</orgName>
								<orgName type="institution">McGill University</orgName>
								<address>
									<settlement>Montreal</settlement>
									<region>Quebec</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eitan</forename><surname>Friedman</surname></persName>
							<affiliation key="aff49">
								<orgName type="department">Sackler Faculty of Medicine</orgName>
								<orgName type="laboratory">The Susanne Levy Gertner Oncogenetics Unit</orgName>
								<orgName type="institution" key="instit1">Institute of Human Genetics</orgName>
								<orgName type="institution" key="instit2">Chaim Sheba Medical Center</orgName>
								<address>
									<settlement>Ramat Gan 52621</settlement>
								</address>
							</affiliation>
							<affiliation key="aff50">
								<orgName type="institution">Tel Aviv University</orgName>
								<address>
									<addrLine>Ramat Aviv 69978</addrLine>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Debra</forename><surname>Frost</surname></persName>
							<affiliation key="aff41">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
							</affiliation>
							<affiliation key="aff42">
								<orgName type="laboratory">Strangeways Research Laboratory</orgName>
								<address>
									<addrLine>Worts Causeway</addrLine>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pragna</forename><surname>Gaddam</surname></persName>
							<affiliation key="aff51">
								<orgName type="laboratory">Clinical Cancer Genetics Laboratory</orgName>
								<orgName type="institution">Memorial Sloane Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff52">
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>40</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff53">
								<orgName type="department">Division of Cancer Prevention &amp; Control Research</orgName>
								<orgName type="institution" key="instit1">UCLA Schools of Medicine and Public Health</orgName>
								<orgName type="institution" key="instit2">Jonsson Comprehensive Cancer Center</orgName>
								<address>
									<addrLine>650 Charles Young Drive South</addrLine>
									<postCode>A2-125 HS, 90095-6900</postCode>
									<settlement>Room, Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
							<affiliation key="aff54">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patricia</forename><forename type="middle">A</forename><surname>Ganz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Judy</forename><surname>Garber</surname></persName>
							<affiliation key="aff55">
								<orgName type="department">Dana-Farber Cancer Institute</orgName>
								<orgName type="institution">Cancer Risk and Prevention Clinic</orgName>
								<address>
									<addrLine>450 Brookline Avenue</addrLine>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff56">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vanesa</forename><surname>Garcia-Barberan</surname></persName>
							<affiliation key="aff18">
								<orgName type="laboratory">Molecular Oncology Laboratory</orgName>
								<orgName type="institution" key="instit1">Hospital Clinico San Carlos</orgName>
								<orgName type="institution" key="instit2">IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)</orgName>
								<address>
									<addrLine>Martin Lagos s/n</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marion</forename><surname>Gauthier-Villars</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de Génétique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff89">
								<address>
									<postCode>00029 HUS</postCode>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Gehrig</surname></persName>
							<affiliation key="aff57">
								<orgName type="department" key="dep1">Centre of Familial Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Department of Medical Genetics</orgName>
								<orgName type="department" key="dep3">Institute of Human Genetics</orgName>
								<orgName type="institution">University Würzburg</orgName>
								<address>
									<settlement>Würzburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anne-Marie</forename><surname>Gerdes</surname></persName>
							<affiliation key="aff58">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<address>
									<addrLine>Rigshospitalet 4062, Blegdamsvej 9, København Ø</addrLine>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sophie</forename><surname>Giraud</surname></persName>
							<affiliation key="aff59">
								<orgName type="laboratory">Service de Génétique Moléculaire et Clinique</orgName>
								<address>
									<settlement>Hospices Civils de Lyon, Lyon cedex 04</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">K</forename><surname>Godwin</surname></persName>
							<affiliation key="aff60">
								<orgName type="department">Department of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution">University of Kansas</orgName>
								<address>
									<addrLine>3901 Rainbow Boulevard, 4019 Wahl Hall East</addrLine>
									<postCode>3040</postCode>
									<region>MS</region>
								</address>
							</affiliation>
							<affiliation key="aff61">
								<orgName type="department">Medical Center</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>Kansas</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">E</forename><surname>Goldgar</surname></persName>
							<affiliation key="aff62">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Utah School of Medicine</orgName>
								<address>
									<addrLine>30 North, SOM 4B454</addrLine>
									<postCode>1900, 84132</postCode>
									<settlement>East, Salt Lake City</settlement>
									<region>UT</region>
								</address>
							</affiliation>
							<affiliation key="aff63">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">R</forename><surname>Hake</surname></persName>
							<affiliation key="aff64">
								<orgName type="institution">City of Hope Clinical Cancer Genetics Community Research Network</orgName>
								<address>
									<addrLine>1500 East Duarte Road</addrLine>
									<postCode>91010</postCode>
									<settlement>Duarte</settlement>
									<region>CA</region>
								</address>
							</affiliation>
							<affiliation key="aff65">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">V O</forename><surname>Hansen</surname></persName>
							<affiliation key="aff66">
								<orgName type="department">Center for Genomic Medicine</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<addrLine>Blegdamsvej 9</addrLine>
									<postCode>DK-2100</postCode>
									<settlement>Rigshospitalet, Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sue</forename><surname>Healey</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<addrLine>Herston Road</addrLine>
									<postCode>4029</postCode>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shirley</forename><surname>Hodgson</surname></persName>
							<affiliation key="aff67">
								<orgName type="department">Medical Genetics Unit</orgName>
								<orgName type="institution">University of London</orgName>
								<address>
									<addrLine>50 Family Cancer Clinic</addrLine>
									<settlement>St George&apos;s, London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff68">
								<orgName type="department">51 Center for Medical Genetics</orgName>
								<orgName type="institution">Netherlands Cancer Institute</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<postBox>P.O. Box 90203</postBox>
									<postCode>1000 BE</postCode>
									<settlement>Amsterdam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff69">
								<orgName type="institution" key="instit1">NorthShore University Health System</orgName>
								<orgName type="institution" key="instit2">University of Chicago Pritzker School of Medicine</orgName>
								<address>
									<addrLine>1000 Central Street, Suite 620</addrLine>
									<postCode>60201</postCode>
									<settlement>Evanston</settlement>
									<region>IL</region>
								</address>
							</affiliation>
							<affiliation key="aff70">
								<orgName type="department">52 N.N. Petrov Institute of Oncology</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<postCode>197758</postCode>
									<settlement>St.-Petersburg</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Frans</forename><forename type="middle">B L</forename><surname>Hogervorst</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Claude</forename><surname>Houdayer</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de Génétique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff89">
								<address>
									<postCode>00029 HUS</postCode>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Hulick</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Evgeny</forename><forename type="middle">N</forename><surname>Imyanitov</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Claudine</forename><surname>Isaacs</surname></persName>
							<affiliation key="aff71">
								<orgName type="department">Lombardi Comprehensive Cancer Center</orgName>
								<orgName type="institution">Georgetown University</orgName>
								<address>
									<addrLine>3800 Reservoir Road NW</addrLine>
									<settlement>Washington</settlement>
									<region>DC</region>
								</address>
							</affiliation>
							<affiliation key="aff72">
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>54 Clinical Genetics, Guy&apos;s and St</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff73">
								<orgName type="institution">Thomas&apos; NHS Foundation Trust</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Louise</forename><surname>Izatt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Angel</forename><surname>Izquierdo</surname></persName>
							<affiliation key="aff74">
								<orgName type="department">IDIBGI (Institut d&apos;Investigació Biomèdica de Girona)</orgName>
								<orgName type="laboratory">Genetic Counseling Unit, Hereditary Cancer Program</orgName>
								<orgName type="institution" key="instit1">Catalan Institute of Oncology</orgName>
								<orgName type="institution" key="instit2">Av. França s/n</orgName>
								<address>
									<postCode>1707</postCode>
									<settlement>Girona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lauren</forename><surname>Jacobs</surname></persName>
							<affiliation key="aff75">
								<orgName type="department">Dept. of Medicine</orgName>
								<orgName type="laboratory">Clinical Genetics Research Laboratory</orgName>
								<orgName type="institution">Memorial PLOS ONE |</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Jakubowska</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<addrLine>Polabska 4</addrLine>
									<settlement>Szczecin</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ramunas</forename><surname>Janavicius</surname></persName>
							<affiliation key="aff78">
								<orgName type="department" key="dep1">Dept. of Molecular and Regenerative Medicine</orgName>
								<orgName type="department" key="dep2">Santariskiu st</orgName>
								<orgName type="department" key="dep3">State Research Institute Centre for Innovative medicine</orgName>
								<orgName type="laboratory">Hematology, oncology and transfusion medicine center</orgName>
								<orgName type="institution">Vilnius University Hospital Santariskiu Clinics</orgName>
								<address>
									<addrLine>Zygymantu st. 9</addrLine>
									<settlement>Vilnius</settlement>
									<country key="LT">Lithuania</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katarzyna</forename><surname>Jaworska- Bieniek</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Uffe</forename><surname>Birk Jensen</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<addrLine>Polabska 4</addrLine>
									<settlement>Szczecin</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
							<affiliation key="aff79">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Aarhus University Hospital</orgName>
								<address>
									<addrLine>Brendstrupgaardsvej 21C, Aarhus N</addrLine>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Esther</forename><forename type="middle">M</forename><surname>John</surname></persName>
							<affiliation key="aff80">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Cancer Prevention Institute of California</orgName>
								<address>
									<addrLine>2201 Walnut Avenue, Suite 300</addrLine>
									<postCode>94538</postCode>
									<settlement>Fremont</settlement>
									<region>CA</region>
								</address>
							</affiliation>
							<affiliation key="aff81">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joseph</forename><surname>Vijai</surname></persName>
							<affiliation key="aff82">
								<orgName type="department">Dept. of Medicine</orgName>
								<orgName type="laboratory">Clinical Genetics Research Laboratory</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10044</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff83">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Beth</forename><forename type="middle">Y</forename><surname>Karlan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Kast</surname></persName>
							<affiliation key="aff86">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution" key="instit1">University Hospital Carl Gustav Carus</orgName>
								<orgName type="institution" key="instit2">Technical University Dresden</orgName>
								<address>
									<settlement>Dresden, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kconfab</forename><surname>Investigators</surname></persName>
							<affiliation key="aff87">
								<orgName type="institution" key="instit1">Kathleen Cuningham Consortium for Research into Familial Breast Cancer</orgName>
								<orgName type="institution" key="instit2">Peter MacCallum Cancer Center</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sofia</forename><surname>Khan</surname></persName>
							<affiliation key="aff88">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<addrLine>Biomedicum Helsinki</addrLine>
									<postBox>P.O. BOX 700</postBox>
									<settlement>Haartmaninkatu</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ava</forename><surname>Kwong</surname></persName>
							<affiliation key="aff90">
								<orgName type="department">Cancer Genetics Center</orgName>
								<orgName type="institution" key="instit1">The Hong Kong Hereditary Breast Cancer Family Registry</orgName>
								<orgName type="institution" key="instit2">Hong Kong Sanatorium and Hospital</orgName>
								<address>
									<settlement>Hong Kong China</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yael</forename><surname>Laitman</surname></persName>
							<affiliation key="aff91">
								<orgName type="institution" key="instit1">The Susanne Levy Gertner Oncogenetics Unit</orgName>
								<orgName type="institution" key="instit2">Institute of Human Genetics</orgName>
							</affiliation>
							<affiliation key="aff92">
								<orgName type="institution">Chaim Sheba Medical Center</orgName>
								<address>
									<settlement>Ramat Gan 52621</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jenny</forename><surname>Lester</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fabienne</forename><surname>Lesueur</surname></persName>
							<affiliation key="aff93">
								<orgName type="department" key="dep1">Genetic Epidemiology of Cancer team</orgName>
								<orgName type="department" key="dep2">Inserm U900</orgName>
								<orgName type="department" key="dep3">Institut Curie</orgName>
								<address>
									<addrLine>Mines ParisTech, 26 rue d&apos;Ulm</addrLine>
									<postCode>75248, cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annelie</forename><surname>Liljegren</surname></persName>
							<affiliation key="aff94">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution">Karolinska University Hospital</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Lubinski</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<addrLine>Polabska 4</addrLine>
									<settlement>Szczecin</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Phuong</forename><forename type="middle">L</forename><surname>Mai</surname></persName>
							<affiliation key="aff95">
								<orgName type="department" key="dep1">Clinical Genetics Branch</orgName>
								<orgName type="department" key="dep2">DCEG</orgName>
								<orgName type="department" key="dep3">Medical Center Drive</orgName>
								<orgName type="institution">NCI, NIH</orgName>
								<address>
									<postCode>9609, 6E-454</postCode>
									<settlement>Room, Bethesda</settlement>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff96">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Siranoush</forename><surname>Manoukian</surname></persName>
							<affiliation key="aff97">
								<orgName type="department">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="institution" key="instit1">Unit of Medical Genetics</orgName>
								<orgName type="institution" key="instit2">Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)</orgName>
								<address>
									<addrLine>Via Giacomo Venezian 1</addrLine>
									<postCode>20133</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sylvie</forename><surname>Mazoyer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alfons</forename><surname>Meindl</surname></persName>
							<affiliation key="aff98">
								<orgName type="department" key="dep1">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="department" key="dep2">Division of Tumor Genetics</orgName>
								<orgName type="department" key="dep3">Klinikum rechts der Isar</orgName>
								<orgName type="institution">Technical University Munich</orgName>
								<address>
									<settlement>Munich, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Arjen</forename><forename type="middle">R</forename><surname>Mensenkamp</surname></persName>
							<affiliation key="aff99">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution">Radboud university medical centre</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<postBox>P.O. Box 9101</postBox>
									<postCode>6500 HB</postCode>
									<settlement>Nijmegen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Montagna</surname></persName>
							<affiliation key="aff100">
								<orgName type="laboratory">Immunology and Molecular Oncology Unit</orgName>
								<orgName type="institution">Veneto Institute of Oncology IOV-IRCCS</orgName>
								<address>
									<addrLine>Via Gattamelata 64</addrLine>
									<settlement>Padua</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katherine</forename><forename type="middle">L</forename><surname>Nathanson</surname></persName>
							<affiliation key="aff31">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Abramson Cancer Center</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<addrLine>3400 Civic Center Boulevard</addrLine>
									<postCode>19104</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff32">
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>26 Genomics Center</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff33">
								<orgName type="institution" key="instit1">Centre Hospitalier Universitaire de Québec Research Center</orgName>
								<orgName type="institution" key="instit2">Laval University</orgName>
								<address>
									<addrLine>2705 Laurier Boulevard</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff34">
								<orgName type="institution">Quebec City (Quebec)</orgName>
								<address>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">L</forename><surname>Neuhausen</surname></persName>
							<affiliation key="aff101">
								<orgName type="department">Department of Population Sciences</orgName>
								<orgName type="institution">Beckman Research Institute of City of Hope</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA</region>
								</address>
							</affiliation>
							<affiliation key="aff102">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Heli</forename><surname>Nevanlinna</surname></persName>
							<affiliation key="aff88">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<addrLine>Biomedicum Helsinki</addrLine>
									<postBox>P.O. BOX 700</postBox>
									<settlement>Haartmaninkatu</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dieter</forename><surname>Niederacher</surname></persName>
							<affiliation key="aff103">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution" key="instit1">University Hospital Düsseldorf</orgName>
								<orgName type="institution" key="instit2">Heinrich-Heine University Düsseldorf</orgName>
								<address>
									<settlement>Düsseldorf, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Edith</forename><surname>Olah</surname></persName>
							<affiliation key="aff104">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">National Institute of Oncology</orgName>
								<address>
									<settlement>Budapest</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Olufunmilayo</forename><forename type="middle">I</forename><surname>Olopade</surname></persName>
							<affiliation key="aff105">
								<orgName type="department">Regional Genetics Service</orgName>
								<orgName type="institution">The University of Chicago Medicine</orgName>
								<address>
									<addrLine>5841 South Maryland Avenue, 78 West Midlands</addrLine>
									<postCode>2115, 60637</postCode>
									<settlement>Chicago</settlement>
									<region>MC, IL</region>
								</address>
							</affiliation>
							<affiliation key="aff106">
								<orgName type="institution">Birmingham Women&apos;s Hospital Healthcare NHS Trust</orgName>
								<address>
									<addrLine>Edgbaston</addrLine>
									<settlement>Birmingham</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kai-Ren</forename><surname>Ong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>Osorio</surname></persName>
							<affiliation key="aff107">
								<orgName type="laboratory">Human Genetics Group</orgName>
								<orgName type="institution">Spanish National Cancer Centre (CNIO)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sue</forename><forename type="middle">Kyung</forename><surname>Park</surname></persName>
							<affiliation key="aff108">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Department of Biomedical Science</orgName>
								<orgName type="institution" key="instit1">Seoul National University College of Medicine</orgName>
								<orgName type="institution" key="instit2">Seoul National University Graduate School, and Cancer Research Institute</orgName>
								<orgName type="institution" key="instit3">Seoul National University</orgName>
								<address>
									<addrLine>103 Daehak-ro, Jongno-gu</addrLine>
									<postCode>110-799</postCode>
									<settlement>Seoul, Korea</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ylva</forename><surname>Paulsson-Karlsson</surname></persName>
							<affiliation key="aff109">
								<orgName type="department">Department of Immunology, Genetics and Pathology</orgName>
								<orgName type="institution">Uppsala University</orgName>
								<address>
									<postCode>SE-751 85</postCode>
									<settlement>Uppsala, Sweden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Inge</forename><surname>Sokilde Pedersen</surname></persName>
							<affiliation key="aff110">
								<orgName type="department" key="dep1">Section of Molecular Diagnostics</orgName>
								<orgName type="department" key="dep2">Department of Biochemistry</orgName>
								<orgName type="institution">Aalborg University Hospital</orgName>
								<address>
									<addrLine>Reberbansgade 15</addrLine>
									<settlement>Aalborg</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernard</forename><surname>Peissel</surname></persName>
							<affiliation key="aff97">
								<orgName type="department">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="institution" key="instit1">Unit of Medical Genetics</orgName>
								<orgName type="institution" key="instit2">Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)</orgName>
								<address>
									<addrLine>Via Giacomo Venezian 1</addrLine>
									<postCode>20133</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paolo</forename><surname>Peterlongo</surname></persName>
							<affiliation key="aff111">
								<orgName type="institution" key="instit1">IFOM</orgName>
								<orgName type="institution" key="instit2">The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Pfeiler</surname></persName>
							<affiliation key="aff113">
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<addrLine>Währinger Gürtel 18-20</addrLine>
									<postCode>1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catherine</forename><forename type="middle">M</forename><surname>Phelan</surname></persName>
							<affiliation key="aff114">
								<orgName type="department">Department of Cancer Epidemiology</orgName>
								<orgName type="institution">Moffitt Cancer Center</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>Florida</region>
								</address>
							</affiliation>
							<affiliation key="aff115">
								<orgName type="department" key="dep1">86 NRG Oncology, Statistics and Data Management Center</orgName>
								<orgName type="department" key="dep2">Roswell Park Cancer Institute</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>Elm St &amp; Carlton St</addrLine>
									<postCode>14263</postCode>
									<settlement>Buffalo</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff116">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marion</forename><surname>Piedmonte</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bruce</forename><surname>Poppe</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<addrLine>De Pintelaan 185</addrLine>
									<postCode>9000</postCode>
									<settlement>Gent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Miquel</forename><forename type="middle">Angel</forename><surname>Pujana</surname></persName>
							<affiliation key="aff117">
								<orgName type="laboratory">Translational Research Laboratory</orgName>
								<orgName type="institution" key="instit1">IDIBELL (Bellvitge Biomedical Research Institute)</orgName>
								<orgName type="institution" key="instit2">Catalan Institute of Oncology</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paolo</forename><surname>Radice</surname></persName>
							<affiliation key="aff118">
								<orgName type="department">Department of Preventive and Predicted Medicine</orgName>
								<orgName type="institution" key="instit1">Unit of Molecular Bases of Genetic Risk and Genetic Testing</orgName>
								<orgName type="institution" key="instit2">Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gad</forename><surname>Rennert</surname></persName>
							<affiliation key="aff120">
								<orgName type="department" key="dep1">Department of Community Medicine and Epidemiology</orgName>
								<orgName type="department" key="dep2">Carmel Medical Center and B. Rappaport Faculty of Medicine</orgName>
								<orgName type="institution">Clalit National Israeli Cancer Control Center</orgName>
								<address>
									<addrLine>7 Michal St</addrLine>
									<postCode>34362</postCode>
									<settlement>Haifa</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gustavo</forename><forename type="middle">C</forename><surname>Rodriguez</surname></persName>
							<affiliation key="aff121">
								<orgName type="department">Division of Gynecologic Oncology</orgName>
								<orgName type="institution" key="instit1">NorthShore University HealthSystem</orgName>
								<orgName type="institution" key="instit2">Univ of Chicago</orgName>
								<address>
									<addrLine>2650 Ridge Avenue Suite 1507 Walgreens</addrLine>
									<postCode>60201</postCode>
									<settlement>Evanston</settlement>
									<region>IL</region>
								</address>
							</affiliation>
							<affiliation key="aff122">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matti</forename><forename type="middle">A</forename><surname>Rookus</surname></persName>
							<affiliation key="aff123">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">Biostatistics and Bioinformatics Facility</orgName>
								<orgName type="department" key="dep3">Fox Chase Cancer Center</orgName>
								<orgName type="institution">Netherlands Cancer Institute</orgName>
								<address>
									<addrLine>333 Cottman Avenue</addrLine>
									<postBox>P.O. Box 90203</postBox>
									<postCode>1000 BE, 92, 19111</postCode>
									<settlement>Amsterdam, Philadelphia</settlement>
									<region>PA</region>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
							<affiliation key="aff124">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><forename type="middle">A</forename><surname>Ross</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rita</forename><forename type="middle">Katharina</forename><surname>Schmutzler</surname></persName>
							<affiliation key="aff125">
								<orgName type="department">Center for Hereditary Breast and Ovarian Cancer</orgName>
							</affiliation>
							<affiliation key="aff126">
								<orgName type="department">Medical Faculty</orgName>
								<orgName type="institution">University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacques</forename><surname>Simard</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><forename type="middle">F</forename><surname>Singer</surname></persName>
							<affiliation key="aff127">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<addrLine>and Waehringer Guertel 18-20</addrLine>
									<postCode>A 1090</postCode>
									<settlement>Vienna, Vienna</settlement>
									<country>Austria, Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">P</forename><surname>Slavin</surname></persName>
							<affiliation key="aff128">
								<orgName type="department">Clinical Cancer Genetics</orgName>
								<orgName type="institution">City of Hope</orgName>
								<address>
									<addrLine>1500 East Duarte Road</addrLine>
									<postCode>91010</postCode>
									<settlement>Duarte</settlement>
									<region>California</region>
								</address>
							</affiliation>
							<affiliation key="aff129">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Penny</forename><surname>Soucy</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Melissa</forename><surname>Southey</surname></persName>
							<affiliation key="aff130">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="laboratory">Genetic Epidemiology Laboratory</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Doris</forename><surname>Steinemann</surname></persName>
							<affiliation key="aff131">
								<orgName type="department" key="dep1">Institute of Cell and Molecular Pathology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dominique</forename><surname>Stoppa-Lyonnet</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de Génétique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff89">
								<address>
									<postCode>00029 HUS</postCode>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Grzegorz</forename><surname>Sukiennicki</surname></persName>
							<affiliation key="aff35">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<addrLine>Polabska 4</addrLine>
									<settlement>Szczecin</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Sutter</surname></persName>
							<affiliation key="aff132">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Department of Human Genetics</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<settlement>Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Csilla</forename><forename type="middle">I</forename><surname>Szabo</surname></persName>
							<affiliation key="aff133">
								<orgName type="institution" key="instit1">National Human Genome Research Institute</orgName>
								<orgName type="institution" key="instit2">National Institutes of Health</orgName>
								<address>
									<addrLine>Building 50, 50 South Drive, MSC 004</addrLine>
									<postCode>5312, 20892-8004</postCode>
									<settlement>Room, Bethesda</settlement>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff134">
								<orgName type="department" key="dep1">Department of Genetics</orgName>
								<orgName type="department" key="dep2">Portuguese Oncology Institute</orgName>
								<orgName type="department" key="dep3">Cancer Research Initiatives Foundation</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>Rua Dr. António Bernardino de Almeida</addrLine>
									<postCode>100, 4200-072, 101</postCode>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
							<affiliation key="aff135">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Sime Darby Medical Centre</orgName>
								<address>
									<addrLine>1 Jalan SS12/1A, Subang Jaya</addrLine>
									<postCode>47500, 102</postCode>
									<settlement>Malaysia</settlement>
								</address>
							</affiliation>
							<affiliation key="aff136">
								<orgName type="institution">Columbia University</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff137">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution" key="instit1">United States of America</orgName>
								<orgName type="institution" key="instit2">Odense University Hospital</orgName>
								<address>
									<addrLine>Sonder Boulevard 29</addrLine>
									<postCode>103</postCode>
								</address>
							</affiliation>
							<affiliation key="aff138">
								<orgName type="institution">Odense C</orgName>
								<address>
									<postCode>104 UO</postCode>
									<settlement>Anatomia Patologica</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff139">
								<orgName type="department" key="dep1">Latvian Biomedical Research and Study Centre</orgName>
								<orgName type="department" key="dep2">Department of Genetics</orgName>
								<orgName type="laboratory">Cancer Genetics Laboratory</orgName>
								<orgName type="institution">Ospedale di Circolo-Università dell&apos;Insubria</orgName>
								<address>
									<addrLine>Via O.Rossi 9, Ratsupites str 1</addrLine>
									<postCode>21100, 105, 106</postCode>
									<settlement>Varese, Italy, Riga</settlement>
									<country key="LV">Latvia</country>
								</address>
							</affiliation>
							<affiliation key="aff140">
								<orgName type="department">Department of Epidemiology, Prevention and Special Functions</orgName>
								<orgName type="laboratory">Unit of Hereditary Cancer</orgName>
								<orgName type="institution">University of Pretoria</orgName>
								<address>
									<addrLine>Private Bag X323, South Africa, 107</addrLine>
									<postCode>0007</postCode>
									<settlement>Arcadia</settlement>
								</address>
							</affiliation>
							<affiliation key="aff141">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Molecular Diagnostics Laboratory</orgName>
								<orgName type="department" key="dep3">Institute of Nuclear and Radiological Sciences and Technology</orgName>
								<orgName type="institution">IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro</orgName>
								<address>
									<addrLine>largo Rosanna Benzi 10, Campus Virchov Klinikum</addrLine>
									<postCode>16132, 108, 109</postCode>
									<settlement>Genoa, Italy, Charite Berlin, Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff142">
								<orgName type="department" key="dep1">Familial Cancer Service</orgName>
								<orgName type="department" key="dep2">Divison of Human Cancer Genetics</orgName>
								<orgName type="department" key="dep3">Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics</orgName>
								<orgName type="department" key="dep4">Comprehensive Cancer Center</orgName>
								<orgName type="institution">National Centre for Scientific Research &quot;Demokritos&quot; Patriarchou Gregoriou &amp; Neapoleos str</orgName>
								<address>
									<addrLine>Aghia Paraskevi, 110 Westmead Hospital, Hawkesbury Road</addrLine>
									<postBox>P.O. Box 533</postBox>
									<postCode>2145, 111</postCode>
									<settlement>Attiki, Athens, Wentworthville</settlement>
									<region>NSW</region>
									<country>Greece, Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff143">
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<postCode>998</postCode>
								</address>
							</affiliation>
							<affiliation key="aff144">
								<orgName type="institution">Biomedical Research Tower</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>OH</region>
								</address>
							</affiliation>
							<affiliation key="aff145">
								<orgName type="department" key="dep1">Molecular Genetics of Breast Cancer</orgName>
								<orgName type="department" key="dep2">German Cancer Research Center (DKFZ)</orgName>
								<orgName type="department" key="dep3">Department of Health Sciences Research</orgName>
								<orgName type="institution">United States of America</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 580</addrLine>
									<postCode>112, 69120, 113</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff146">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<addrLine>13400 E. Scottsdale Blvd</addrLine>
									<settlement>Scottsdale</settlement>
									<region>AZ</region>
								</address>
							</affiliation>
							<affiliation key="aff147">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Keck School of Medicine</orgName>
								<orgName type="department" key="dep3">United States of America</orgName>
								<orgName type="department" key="dep4">Department of Laboratory Medicine and Pathology</orgName>
								<orgName type="department" key="dep5">Dept. of Medicine, Cancer Biology and Genetics</orgName>
								<orgName type="laboratory">Clinical Genetics Research Laboratory</orgName>
								<orgName type="institution" key="instit1">United States of America</orgName>
								<orgName type="institution" key="instit2">University of Southern California</orgName>
								<orgName type="institution" key="instit3">and Health Sciences Research</orgName>
								<orgName type="institution" key="instit4">Mayo Clinic</orgName>
								<address>
									<addrLine>200 First Street SW</addrLine>
									<postCode>114, 115, 116</postCode>
									<settlement>Rochester</settlement>
									<region>California, Minnesota</region>
									<country>United States of America</country>
								</address>
							</affiliation>
							<affiliation key="aff148">
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10044</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff149">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution" key="instit1">United States of America</orgName>
								<orgName type="institution" key="instit2">University of Cambridge</orgName>
								<address>
									<postCode>117</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Muy-Kheng</forename><surname>Tea</surname></persName>
							<affiliation key="aff127">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<addrLine>and Waehringer Guertel 18-20</addrLine>
									<postCode>A 1090</postCode>
									<settlement>Vienna, Vienna</settlement>
									<country>Austria, Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><forename type="middle">R</forename><surname>Teixeira</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Soo-Hwang</forename><surname>Teo</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">Beth</forename><surname>Terry</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mads</forename><surname>Thomassen</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><forename type="middle">Grazia</forename><surname>Tibiletti</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laima</forename><surname>Tihomirova</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Silvia</forename><surname>Tognazzo</surname></persName>
							<affiliation key="aff100">
								<orgName type="laboratory">Immunology and Molecular Oncology Unit</orgName>
								<orgName type="institution">Veneto Institute of Oncology IOV-IRCCS</orgName>
								<address>
									<addrLine>Via Gattamelata 64</addrLine>
									<settlement>Padua</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elizabeth</forename><forename type="middle">J</forename><surname>Van Rensburg</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Liliana</forename><surname>Varesco</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raymonda</forename><surname>Varon-Mateeva</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Athanassios</forename><surname>Vratimos</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jeffrey</forename><forename type="middle">N</forename><surname>Weitzel</surname></persName>
							<affiliation key="aff128">
								<orgName type="department">Clinical Cancer Genetics</orgName>
								<orgName type="institution">City of Hope</orgName>
								<address>
									<addrLine>1500 East Duarte Road</addrLine>
									<postCode>91010</postCode>
									<settlement>Duarte</settlement>
									<region>California</region>
								</address>
							</affiliation>
							<affiliation key="aff129">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lesley</forename><surname>Mcguffog</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Judy</forename><surname>Kirk</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Dept of OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Amanda</forename><forename type="middle">Ewart</forename><surname>Toland</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ute</forename><surname>Hamann</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff16">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Genetics</orgName>
								<orgName type="department" key="dep2">Istituto Europeo di Oncologia (IEO)</orgName>
								<address>
									<addrLine>via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Noralane</forename><surname>Lindor</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Royal Devon &amp; Exeter Hospital</orgName>
								<address>
									<settlement>Exeter</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">J</forename><surname>Ramus</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="laboratory">Molecular Oncology Laboratory</orgName>
								<orgName type="institution" key="instit1">Hospital Clinico San Carlos</orgName>
								<orgName type="institution" key="instit2">IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)</orgName>
								<address>
									<addrLine>Martin Lagos s/n</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Greene</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff95">
								<orgName type="department" key="dep1">Clinical Genetics Branch</orgName>
								<orgName type="department" key="dep2">DCEG</orgName>
								<orgName type="department" key="dep3">Medical Center Drive</orgName>
								<orgName type="institution">NCI, NIH</orgName>
								<address>
									<postCode>9609, 6E-454</postCode>
									<settlement>Room, Bethesda</settlement>
									<region>MD</region>
								</address>
							</affiliation>
							<affiliation key="aff96">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fergus</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Section of Genetic Oncology</orgName>
								<orgName type="department" key="dep2">Dept. of Laboratory Medicine</orgName>
								<orgName type="department" key="dep3">16 Research Division</orgName>
								<orgName type="institution">University and University Hospital of Pisa</orgName>
								<address>
									<settlement>Pisa Italy</settlement>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="institution">Peter MacCallum Cancer Centre</orgName>
								<address>
									<addrLine>Locked Bag 1, A&apos;Beckett Street, 17 1600 Divisadero Street</addrLine>
									<postCode>8006, C415, 94143-1714</postCode>
									<settlement>Melbourne, San Francisco</settlement>
									<region>VIC, CA</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kenneth</forename><surname>Offit</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><forename type="middle">D P</forename><surname>Pharoah</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<addrLine>Kabbeltoft 25</addrLine>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georgia</forename><surname>Chenevix-Trench</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<addrLine>Herston Road</addrLine>
									<postCode>4029</postCode>
									<settlement>Brisbane</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Antonis</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
							<email>antonis@srl.cam.ac.uk</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="institution">National Cancer Institute</orgName>
								<address>
									<settlement>Olsson</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="institution" key="instit1">National Institutes of Health</orgName>
								<orgName type="institution" key="instit2">UNITED STATES</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="laboratory">(CEGEN) Unit, Human Cancer Genetics Program</orgName>
								<orgName type="institution">Spanish National Cancer Research Centre (CNIO)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff76">
								<orgName type="institution">Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff77">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff84">
								<orgName type="institution">Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center</orgName>
								<address>
									<addrLine>8700 Beverly Boulevard, Suite 290W</addrLine>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff85">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff112">
								<orgName type="institution">IFOM-IEO campus</orgName>
								<address>
									<addrLine>via Adamello 16</addrLine>
									<postCode>20139</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff119">
								<address>
									<addrLine>via GA Amadeo 42</addrLine>
									<postCode>20133</postCode>
									<settlement>Amaedeolab, Milan, Italy</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-27">July 27, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">182E9AC0F6F14141329A463A8F8AAFD5</idno>
					<idno type="DOI">10.1371/journal.pone.0158801</idno>
					<note type="submission">Received: March 12, 2016 Accepted: June 22, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>index.</s><s>html) for researchers who meet the criteria for access to confidential data.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Once age is taken into account, family history is the strongest risk factor for ovarian cancer.</s><s>Women with a first-degree relative with ovarian cancer are at a 3-fold increased risk of developing the disease, indicating the importance of genetic factors in ovarian cancer predisposition.</s><s>The most important genes in the context of genetic counseling for ovarian cancer susceptibility are BRCA1 and BRCA2, which account for approximately 24% of the familial risk among first-degree relatives <ref type="bibr" target="#b0">[1]</ref>.</s><s>In contrast to the general population, in which the lifetime risk of developing ovarian carcinoma is 1.6% (average age at diagnosis 63 years), women carrying a BRCA1 mutation have a lifetime risk of 35-60% with an average age of diagnosis of 50 years <ref type="bibr" target="#b1">[2]</ref>.</s><s>The ovarian cancer penetrance is lower for BRCA2, with a lifetime risk of 12-25% and an average age of diagnosis of 60 years <ref type="bibr" target="#b1">[2]</ref>.</s><s>The majority of BRCA1/2 associated ovarian cancers present as high-grade serous histology in advanced stage <ref type="bibr" target="#b2">[3]</ref>.</s></p><p><s>Genome wide association studies have identified several common germline variants associated with ovarian cancer risk.</s><s>The 9p22 locus was first found to be associated with ovarian cancer risk in the general population, and subsequently to be an ovarian cancer risk modifier in BRCA1 and BRCA2 mutation carriers <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>The SNP showing the strongest association in the general population was rs3814113, which was associated with a decrease in the risk of ovarian cancer in carriers of the minor allele (OR per allele = 0.82, 95%CI: 0.79 to 0.86, pvalue = 5.1 × 10−19) <ref type="bibr" target="#b4">[5]</ref> and had a similar association with ovarian cancer risk for BRCA1 and BRCA2 mutation carriers <ref type="bibr" target="#b3">[4]</ref>.</s><s>rs3814113 lies in a 150-kb linkage disequilibrium (LD) block.</s><s>The closest genes to rs3814113 are Basonuclin 2(BNC2) and Centlein (CNTLN).</s><s>BNC2 is a zinc-finger protein spanning nucleotides 16409503 to 16870706.</s><s>It is expressed in ovary, testis and the male germ line where it regulates cell cycle progression <ref type="bibr" target="#b5">[6]</ref>.</s><s>CNTLN spans nucleotides 17134982 to 17503923, it is ubiquitously expressed and localises at centrosomes to ensure centrosome function during cell division <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>However, no fine-scale mapping of this locus has been reported yet in either the general population or in mutation carriers.</s><s>Therefore, it is unclear which are the likely causal variants in the region.</s></p><p><s>Here, we report the fine-scale mapping of the 9p22.2</s><s>locus using data from 15252 BRCA1 and 8211 BRCA2 mutation carriers of European ancestry.</s><s>We comprehensively characterized the associations of genetic variants in the region with ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Population</head><p><s>Epidemiological and genotype data were obtained from BRCA1 and BRCA2 mutation carriers participating in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA, <ref type="bibr" target="#b8">[9]</ref>).</s><s>Eligibility to CIMBA was restricted to women older than age 18 years who carried pathogenic mutations in the BRCA1 or BRCA2 genes.</s><s>For each mutation carrier, date of birth, age at cancer diagnosis, age at bilateral prophylactic mastectomy and/or oophorectomy, age at interview or last follow-up, exact BRCA1 and BRCA2 mutation description and self-reported ethnicity were recorded, together with tumor pathology, survival, treatment and other established lifestyle/ hormonal risk factors for breast or ovarian cancer.</s><s>Participants were recruited from 25 countries under ethically approved protocols and provided written informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping and Imputation</head><p><s>Genotyping was performed using the iCOGS Illumina array <ref type="bibr" target="#b9">[10]</ref>.</s><s>The quality control (QC) of the genotyping data has been described in detail previously <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>The iCOGS array included SNPs for fine mapping of the 9p22.2</s><s>region.</s><s>The fine mapping region was defined as Chromosome 9 positions: 16407967 to 17407967 (NCBI build 37).</s><s>To select the SNPs for inclusion on iCOGS, we considered all variants with minor allele frequencies of &gt;0.02 from the 1000 Genomes Project (March 2010 version) and selected SNPs that were correlated at r 2 &gt;0.1 with the SNP that had been identified through the GWAS (rs3814113), and the set of SNPs that tagged all remaining SNPs in the region with r 2 &gt;0.9.</s><s>A total of 407 and 401 SNPs that were included on iCOGS in the 9p22.2</s><s>region passed QC and were available for the analyses for BRCA1 and BRCA2 mutation carriers, respectively.</s><s>Imputation of genotypes was based on the phase 3 release of the 1000 Genome Project spanning nucleotides 16407967 to 17407967 (build 37) at chromosome 9 with a buffer region of 500bp, using IMPUTE2 v2 <ref type="bibr" target="#b12">[13]</ref>.</s><s>SNPs with an "info" metric lower than 0.3 were considered poorly imputed and excluded from downstream analyses.</s><s>In addition, SNPs with a minor allele frequency (MAF) lower than 0.005 were excluded from the association analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis and Computational Methods</head><p><s>The primary analysis evaluated the association between each variant and ovarian cancer risk.</s><s>To account for the non-random sampling of mutation carriers with respect to disease status, the analysis was conducted within a retrospective cohort framework by modeling the likelihood of the observed genotypes conditional on the disease phenotypes as previously described <ref type="bibr" target="#b13">[14]</ref>.</s><s>Each mutation carrier was followed until the first of: ovarian cancer diagnosis, risk-reducing salpingo-oophorectomy or age at last observation.</s><s>Only those diagnosed with ovarian cancer were considered as cases.</s><s>The effect of each SNP was modeled as a per-allele Hazard Ratio (HR).</s><s>To account for related individuals in the sample, a kinship-adjusted version of the score test for association was used which accounts for the correlation between the genotypes of the relatives <ref type="bibr" target="#b14">[15]</ref>.</s><s>Analyses were carried out separately for BRCA1 and BRCA2 mutation carriers and all analyses were stratified by country of residence and year of birth.</s><s>The USA and Canada strata were further subdivided by reported Ashkenazi Jewish ancestry.</s></p><p><s>Ovarian cancer associations were combined in a meta-analysis between BRCA1 and BRCA2 mutation carriers.</s><s>A fixed effect meta-analysis weighted by the inverse variance was conducted for imputed and genotyped SNPs when risk estimates were available in both datasets.</s><s>For BRCA1 and BRCA2 mutation carriers, logarithms of per-allele HR estimates were used.</s><s>The Cochran Q test was carried out to assess heterogeneity.</s></p><p><s>To assess the number of variants independently associated with ovarian cancer risk in BRCA1 and BRCA2 mutation carriers, each SNP was included in a Cox-regression model conditioned on the most strongly associated variant for each dataset and further adjusting by year of birth, and stratifying by country of residence.</s><s>This approach has been shown to yield valid tests of association <ref type="bibr" target="#b15">[16]</ref>.</s><s>All SNPs with a MAF&gt;0.005, and imputation accuracy higher than 0.3, were included.</s><s>For single SNP associations, associations were considered significant if p&lt;5x10 -8 .</s><s>The most parsimonious model in the conditional analyses was identified using a threshold of p&lt;10 −4 for retaining SNPs in the model.</s></p><p><s>The set of potential causal SNPs was defined by those SNPs for which their likelihood ratio relative to the most significant variant was equal or less than 100 and having a pair-wise correlation (r2) with the top SNP higher than 0.1 <ref type="bibr" target="#b16">[17]</ref>.</s></p><p><s>BEDTools was used to intersect positions of ovarian cancer risk-associated variants with functional genomic features generated by Coetzee et al <ref type="bibr" target="#b17">[18]</ref> including FAIRE-seq identified regulatory elements and enhancers identified by histone modification ChIP-seq.</s><s>Variants implicated by overlap were then queried with HaploReg v3 (http://www.broadinstitute.org/</s><s>mammals/haploreg/haploreg_v3.php).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics statement</head><p><s>Each of the host institutions recruited under ethically approved protocols.</s><s>A list of the local Institutional Review Boards that provided ethical approval for this study is given in S1 Table.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association of the 9p22.2 Locus with Ovarian Cancer Risk in BRCA1 Mutation Carriers</head><p><s>Data were available for 15,252 BRCA1 mutation carriers of whom 2,462 were censored at ovarian cancer diagnosis (S2 Table <ref type="table">)</ref>.</s><s>After quality control, data for 407 SNPs genotyped through the iCOGS array spanning chromosome 9 from positions 16424985 to 174 04464 (Genome built 37) were available.</s><s>A further 36,769 SNPs were imputed using the 1000 Genome Project as reference panel.</s><s>Of those, 4,873 had a MAF higher than 0.005 and were considered reliably imputed (IMPUTE2 "info" score &gt; 0.3), and were included in the association analysis.</s></p><p><s>The strongest associated variant was the imputed SNP rs10124837 (per allele HR = 0.73; 95%CI = 0.68-0.79;</s><s>p = 2.0×10−16, Fig 1A, Table <ref type="table">1 and S1 Table) located</ref> 12 kb upstream of BNC2.</s><s>SNP rs3814113 that was originally identified through the GWAS demonstrated a weaker association (p = 5.2x10 -13 ).</s><s>The correlation between the top SNP and the rs3814113 was 0.56 (Table <ref type="table">2</ref>).</s><s>In total, 292 SNPs showed evidence of association with ovarian cancer risk (p: 10</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association of the 9p22.2 Locus with Ovarian Cancer Risk in BRCA2 Mutation Carriers</head><p><s>A total of 8,211 BRCA2 mutation carriers were included in the analysis, of whom 631 were censored at ovarian cancer diagnosis (S2 Table <ref type="table">)</ref>.</s><s>The association analysis included 5,020 SNPs (401 genotyped) with MAF&gt;0.005 that were reliably imputed (IMPUTE2 "info" score greater than 0.3).</s><s>The strongest associated SNP with ovarian cancer risk was rs62543585, with a MAF of 0.20 and a per-allele HR = 0.69 (95%CI = 0.59-0.80;</s><s>p = 1.0 × 10−6, Table <ref type="table">1</ref>).</s><s>SNP rs3814113 demonstrated a slightly weaker association (p = 6.7x10 -6 Table <ref type="table">1</ref>, r 2 with SNP rs62543583 = 0.48, Table <ref type="table">2</ref>).</s><s>Although for BRCA2 mutation carriers the p-values did not reach GWAS statistical significance (5x10 -8 ), given the strong prior evidence of association between SNPs in the region and risk for BRCA1 carriers and in the general population we selected the most significant SNPs as associated with ovarian cancer risk.</s><s>Results for all SNPs with p&lt;0.01 are presented in S3 Table.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Meta-analysis of BRCA1 and BRCA2 Mutation Carriers</head><p><s>Since the majority of both BRCA1 and BRCA2 ovarian cancer associated cancer tumors are high-grade serous ( <ref type="bibr" target="#b18">[19]</ref> and S2 Table <ref type="table">)</ref> to increase the power of the association analyses, a meta-analysis combining HRs for the association of variants with ovarian cancer risk in BRCA1 and BRCA2 was conducted.</s><s>Variants available in only one of the datasets were excluded from the analysis (40 removed from BRCA1 and 187 from BRCA2).</s><s>In the meta-analysis, the strongest associated variant was the genotyped SNP rs7046326 with a MAF of 0.25 and 0.24 in BRCA1 and BRCA2 mutation carriers, respectively.</s><s>It displayed an HR = 0.74 (95% CI = 0.69-0.79;</s><s>p = 6.2 × 10−21, Table <ref type="table">1 and Fig 2)</ref>.</s><s>The correlation with the top SNP in BRCA1 mutation carriers was 0.88 and with the top SNP in BRCA2 mutation carriers 0.69 (Table <ref type="table">2</ref>).</s><s>In addition, 148 SNPs reached genome wide significance (p &lt; 5 × 10−8) for the association with ovarian cancer risk, including the original GWAS hit rs3814113 (Fig <ref type="figure" target="#fig_2">2</ref>).</s><s>No evidence for heterogeneity in the associations for BRCA1 and BRCA2 mutation carriers was observed (Q-test, p-values &gt;0.5, data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identifying Independent Signals for the Association of 9p22 and Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers</head><p><s>In BRCA1 mutation carriers, no variant displayed evidence of an association at a p &lt;10−4 after analyses conditioning on rs10124837 (S1A Fig) <ref type="figure">.</ref></s><s>The association with rs3814113, the original GWAS hit, became non-significant (p = 0.2) when rs10124837 was included as covariate in the model (S1A Fig and Table <ref type="table">3</ref>).</s><s>Similarly, in BRCA2 mutation carriers no evidence of an association was observed for any variant after conditioning on rs62543585 (p &gt;10−4 S1B Fig) <ref type="figure">.</ref></s><s>Neither rs3814113 nor rs10124837 were significant at p&lt;0.05 when rs62543585 was included as covariate in the model while the latter still displayed an association with p = 5x10 -3 (S1B Fig and</s></p><p><s>Table <ref type="table">3</ref>).</s><s>Taken together, these results indicate that in both BRCA1 and BRCA2 mutation carriers there is only one peak of association with ovarian cancer risk at 9p22.</s></p><p><s>Association of 9p22 and Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers.</s><s>SNPs with a likelihood ratio relative to the most significant variant greater than 100 and having an r2&lt; 0.1 with the index SNP were excluded from being potentially causative.</s><s>In BRCA1 mutation carriers, this identified eight highly correlated SNPs (r 2 &gt;0.8), referred hereafter as the "BRCA1 peak".</s><s>These variants clustered in a 20kb region around the transcription start site of BNC2 (positions: 16,847,520-16,891,647).</s><s>The SNPs in this set displayed MAFs of 0.24-0.28</s><s>and imputation accuracy higher than 0.95 and two out of the eight were genotyped (Fig <ref type="figure" target="#fig_1">1A</ref> and Table <ref type="table">1 and S4 Table)</ref>.</s></p><p><s>In BRCA2 mutation carriers, 100 variants could not be rejected from being potentially causal.</s><s>The MAFs for these SNPs varied from 0.15 to 0.34 and had pairwise correlations with the index SNP of greater than 0.4 (Fig 1B <ref type="figure">, S4 Table</ref>).</s><s>The quality of imputation was &gt;0.95 for all except two variants (info = 0.68 and 0.46, S4 Table <ref type="table">)</ref>.</s></p><p><s>All except one (imputed SNP rs139555631) of the likely causal variants in BRCA1 mutation carriers were included in the set marking the potentially causal variants defined in BRCA2 mutation carriers.</s><s>However, none of them were ranked within the top 60 associated variants in BRCA2 carriers.</s><s>The index SNP (rs10124837 in BRCA1 mutation carriers was in linkage disequilibrium with the index SNP (rs62543583) in BRCA2 mutation carriers r 2 = 0.76, Fig <ref type="figure" target="#fig_1">1</ref>, Table <ref type="table">2</ref>).</s></p><p><s>The original GWAS hit, rs3814113, was within the set of the strongest associated SNPs in BRCA2 mutation carriers, but was rejected from being potentially causal in BRCA1 mutation carriers.</s></p><p><s>In the BRCA1/2 meta-analysis, eleven SNPs were the set of potentially causal variants, which included the eight identified in BRCA1 plus three only present in the BRCA2 set.</s><s>These eleven variants were highly correlated with the lead SNP of the meta-analysis rs7046326 (r2&gt;0.8).</s><s>Of note, the set excluded the original GWAS hit rs3814113 (Fig 2, S5 Table <ref type="table">)</ref>.</s></p><p><s>Intersection of variants exhibiting the strongest associations with genomic features derived from cultured ovarian and fallopian tube cells revealed several SNPs that may be functionally relevant in influencing risk.</s><s>Fig <ref type="figure" target="#fig_3">3</ref> shows the location of the sets of SNPs associated with ovarian cancer risk in BRCA1 and BRCA2 mutation carriers relative to the BNC2 gene.</s><s>Several potentially functional variants are predicted, including SNPs that lie in regulatory regions identified by FAIRE-and ChIP-seq.</s><s>For example, a cluster of eight SNPs from the BRCA2 set of Table <ref type="table">2</ref>. Pairwise correlations (r 2 ) between selected SNPs.</s><s>SNPs correspond to: rs10124837, the strongest associated in BRCA1; rs62543583, the strongest associated in BRCA2 mutation carriers; rs7046326, the strongest associated in BRCA1/2 meta-analysis; rs3814113, was the strongest associated variant in the initial GWAS analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SNP</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we performed fine-scale mapping of the 9p22.2</s><s>locus using dense genotype data from the iCOGS array in BRCA1 and BRCA2 mutation carriers of European ancestry.</s><s>We identified a set of variants that provided stronger evidence of association than the original GWAS hit.</s></p><p><s>In BRCA1 mutation carriers, one independent set of eight highly correlated (r2&gt;0.8)</s><s>SNPs could not be excluded as being potentially causal for the reported association with ovarian cancer, designated the "BRCA1 peak".</s><s>The BRCA1 peak covers positions 16847520 to 16891647, which lie within or up to 20 kb upstream BNC2.</s><s>Of note, the original GWAS hit rs3814113 was excluded from the candidate causal variants in this peak.</s></p><p><s>For BRCA2 mutation carriers, 100 correlated variants (r2&gt;0.4)</s><s>could not be excluded as potentially causal ("BRCA2 peak").</s><s>The BRCA2 peak spanned positions 16847520 to 16915021, which are up to 44 kb upstream of BNC2 and more than 200kb upstream of CNTLN.</s><s>The increased number of variants in this case is most likely due to reduced statistical power, as the number of BRCA2 mutation carriers diagnosed with ovarian cancer was only one quarter of the number of affected BRCA1 carriers.</s><s>The candidate causal SNPs in the BRCA1 peak were mostly contained within the BRCA2 peak but the strongest associated SNP in BRCA2 was excluded from the BRCA1 peak.</s><s>The current analysis was underpowered to investigate whether the association in BRCA2 mutation carriers is driven by a different set of genetic variants.</s></p><p><s>Under the model of one shared causal variant explaining the association in both BRCA1 and BRCA2 mutation carriers, the meta-analysis would be expected to increase power for refining the set of potential causal variants.</s><s>However, the combined analysis of BRCA1 and BRCA2 mutation carriers defined a set of eleven variants as potentially causal, which corresponded to the eleven strongest associated variants in BRCA1.</s><s>This set excluded rs3814113 that was reported in the ovarian cancer GWAS <ref type="bibr" target="#b4">[5]</ref>.</s><s>The set of candidate causal variants included three additional SNPs that were confidently discarded on the basis of being less than 100 times likely to be causal relative to the strongest associated SNP in the analysis of BRCA1 carriers only.</s></p><p><s>Important differences emerged when we compared the patterns of association in the finescale mapping of 9p22.2 between BRCA1 mutation carriers and results for the most strongly associated SNPs in samples from the general population.</s><s>Table <ref type="table">3</ref>. Conditional associations for BRCA1 and BRCA2 top SNPs.</s><s>The table shows the HR estimate.</s><s>95% CI and p-value for the conditional analysis adjusting for the lead SNP in the univariate analysis for BRCA1 (left hand side) or BRCA2 mutation carriers (right had side).</s><s>SNPs correspond to: rs10124837, the strongest associated in BRCA1; rs62543583, the strongest associated in BRCA2 mutation carriers; rs7046326, the strongest associated in BRCA1/2 meta-analysis; rs3814113, was the strongest associated variant in the initial GWAS analysis.</s><s>"HR", hazard ratio; "CI", confidence interval.</s><s>Fine-mapping results based on iCOGS data from the Ovarian Cancer Association Consortium indicate that SNP rs3814113 remains the most strongly associated SNP at the 9p22.2</s><s>region with serous ovarian cancer, the original GWAS hit (personal communication).</s><s>Based on our results, this SNP can be confidently rejected from the set of possible causal variants in BRCA1 mutation carriers, suggesting that the associations in BRCA1 mutation carriers and in the general population may be driven by different causal variants at the 9p22.2</s><s>locus.</s><s>These results may indicate differences in the underlying causal mechanisms explaining the ovarian cancer associations between BRCA1 mutation carriers and the general population.</s><s>In support of this possibility, differences in the association patterns with ovarian cancer between BRCA1 and the general population have been reported before.</s><s>The 4q32.3 locus is associated with ovarian cancer risk in BRCA1 but not in BRCA2 mutation carriers or the general population <ref type="bibr" target="#b10">[11]</ref>, while the opposite is true for the locus 17q11.2</s><s><ref type="bibr" target="#b20">[21]</ref>.</s><s>However, clearer patterns will hopefully emerge once the fine mapping of the 9p22.2</s><s>region in samples from the general population is completed.</s></p><p><s>As both signals lie in close proximity to the BNC2 gene, and some candidate causal SNPs are eSNPs for BNC2 in whole blood, they may modulate the expression of BNC2 through similar, or different, mechanisms.</s><s>The possibility that the BRCA1 association signal may differ from that in the general population adds extra complexity and reinforces the value of fine-scale mapping in different populations.</s><s>These subtle differences in the patterns of associations depending on the underlying genetic landscape may be difficult to uncover by means other than fine-scale mapping, and thus strengthens the value of this approach for generating hypotheses about the functional basis of different sets of variants.</s></p><p><s>This study cannot exclude the possibility that the actual causal variants were not included in the set of genotyped or well-imputed variants.</s><s>However, the iCOGs array included variants specifically for fine-scale mapping of the 9p22.2</s><s>locus based on data from the 1000 Genomes Project and therefore the region coverage is expected to be high.</s><s>The relatively low number of ovarian cancer cases with tumor morphology information did not allow performing stratified analyses by ovarian cancer histological subtype.</s><s>Studies of ovarian tumours in women with BRCA1 or BRCA2 mutations have shown that BRCA1 and BRCA2 carriers predominantly develop serous disease <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>Of the available data in CIMBA, 67% of all ovarian cancer tumours in our analyses were serous ovarian cancers.</s><s>Our results are therefore more comparable with the associations for serous ovarian cancer in the general population.</s><s>Larger studies will be required to assess whether the patterns of associations differ by ovarian cancer histological subtyped in BRCA1and BRCA2 mutation carriers.</s></p><p><s>Having narrowed down the potential set of causal variants to only eight SNPs in BRCA1 mutation carriers will assist functional studies to identify the gene/s targeted by these variants.</s><s>BNC2 is an obvious candidate gene, given that the putative causal variants are located in/ around its transcription start site.</s><s>Identifying more strongly associated variants with ovarian cancer in the 9p22.2</s><s>region relative to the initial GWAS hit in BRCA1 and BRCA2 mutation carriers will refine the cancer risks associated with this locus further.</s><s>These novel variants can be included in polygenic risk scores for ovarian cancer and hence inform the identification of patients at greater risk of disease.</s><s>The results may also help to deepen our understanding of the biology of ovarian cancer development in BRCA1 and BRCA2 mutation carriers, potentially leading to the development of more effective and personalized treatments.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>−4 to 10 −16 , Fig 1A).</s><s>The correlation between the top SNP and the SNPs in this set varied from 0.1 to 0.9 (Fig 1).</s><s>Results for all SNPs are presented in S3 Table.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Associations between SNPs in 9p22.2 with ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.</s><s>In each plot, the purple diamond corresponds to the strongest associated SNP and the colour code indicates the linkage disequilibrium with respect to this variant.</s><s>Horizontal lines indicate the -log 10 p-value such that the SNPs above the line are the potential causal ones.</s><s>This set was defined based on a likelihood ratio for a particular SNP as being less or equal than 100, relative to the most likely variant and r 2 &gt;0.1.</s><s>(A) BRCA1 mutation carriers, (B) BRCA2 mutation carriers.</s><s>doi:10.1371/journal.pone.0158801.g001</s></p></div></figDesc><graphic coords="8,200.01,78.01,301.89,487.67" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Associations between SNPs in 9p22.2 with ovarian cancer risk for the meta-analysis of BRCA1 and BRCA2 mutation carriers.</s><s>(A) The purple diamond corresponds to the strongest associated SNP and the colour code indicates the linkage disequilibrium with respect to this variant.</s><s>Horizontal lines indicate the -log 10 p-value such that the SNPs above the line are the potential causal ones.</s><s>This set was defined based on a likelihood ratio for a particular SNP as being less or equal than 100, relative to the most likely variant and r 2 &gt;0.1.</s><s>(B) Haplotype block indicating relevant SNPs.</s><s>From left to right the indicated SNPs correspond to: the strongest associated in BRCA1/2 meta-analysis, the strongest in BRCA1 and the strongest in BRCA2.</s><s>doi:10.1371/journal.pone.0158801.g002</s></p></div></figDesc><graphic coords="11,135.84,74.38,440.11,508.31" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Genomic features surrounding the 9p22.2</s><s>locus.</s><s>Illustration of the genomic region (chr9:16,839,835-16,924,468) encompassing peaks (shaded areas) containing candidate causal variants associated with ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.</s><s>Epigenomic data from Coetzee et al., (2015) [20] representing potential regulatory elements in ovarian cells (iOSE4 and iOSE11) and fallopian tube (FTSEC33) cells derived from formaldehyde assisted identification of regulatory elements sequencing (FAIRE-seq) and histone modification ChIP-seq are shown as black bars.</s><s>Variants which overlap one of these features are coloured red.</s><s>Data from the ENCODE project including histone modification ChIP-seq for three modifications (H3K4me1, H3K4me3, and H3K27ac) are shown as coloured histograms, as well as DNaseI hypersensitive site mapping and transcription factor ChIP-seq.</s><s>The positions of all common SNPs from dbSNP build 142 are shown in the lowest track.</s><s>doi:10.1371/journal.pone.0158801.g003</s></p></div></figDesc><graphic coords="13,53.41,78.01,522.72,288.57" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>S5</head><label></label><figDesc><div><p><s>Table.SNPs within 100 times likely of being causal for the association with ovarian cancer in the meta-analysis of BRCA1 and BRCA2 mutation carriers.</s><s>'T' corresponds to genotyped; 'Ref' and 'Eff' correspond to reference and effector allele, respectively; 'MAF' to minimum allele frequency, 'HR' hazard ratio and 'CI' confidence interval.</s><s>Bold cells correspond to the strongest associated SNP in the indicated dataset.</s><s>Green, violet and orange text indicate those SNPs within 100 times likely of being the causal variant/s in BRCA1 and BRCA2 mutation carriers and their meta-analysis, respectively.</s><s>(PDF)S6 Table.Genomic features for selected SNPs associated with ovarian cancer risk in BRCA2 mutation carriers.(XLSX)</s><s>S1 Text.</s><s>Full list of authors and affiliations.</s><s>(DOCX) Paoli Calmettes, Marseille: Hagay Sobol, Violaine Bourdon, Tetsuro Noguchi, Audrey Remenieras, François Eisinger.</s><s>CHU Arnaud-de-Villeneuve, Montpellier: Isabelle Coupier, Pascal Pujol.</s><s>Centre Oscar Lambret, Lille: Jean-Philippe Peyrat, Joëlle Fournier, Françoise Révillion, Philippe Vennin †, Claude Adenis.</s><s>Centre Paul Strauss, Strasbourg: Danièle Muller, Jean-Pierre Fricker.</s><s>Institut Bergonié, Bordeaux: Emmanuelle Barouk-Simonet, Françoise Bonnet, Virginie Bubien, Nicolas Sevenet, Michel Longy.</s><s>Institut Claudius Regaud, Toulouse: Christine Toulas, Rosine Guimbaud, Laurence Gladieff, Viviane Feillel.</s><s>CHU Grenoble: Dominique Leroux, Hélène Dreyfus, Christine Rebischung, Magalie Peysselon.</s><s>CHU Dijon: Fanny Coron, Laurence Faivre.</s><s>CHU St-Etienne: Fabienne Prieur, Marine Lebrun, Caroline Kientz.</s><s>Hôtel Dieu Centre Hospitalier, Chambéry: Sandra Fert Ferrer.</s><s>Centre Antoine Lacassagne, Nice: Marc Frénay.</s><s>CHU Limoges: Laurence Vénat-Bouvet.</s><s>CHU Nantes: Capucine Delnatte.</s><s>CHU Bretonneau, Tours: Isabelle Mortemousque.</s><s>Groupe Hospitalier Pitié-Salpétrière, Paris: Florence Coulet, Chrystelle Colas, Florent Soubrier, Mathilde Warcoin.</s><s>CHU Vandoeuvre-les-Nancy: Johanna Sokolowska, Myriam Bronner.</s><s>CHU Besançon: Marie-Agnès Collonge-Rame, Alexandre Damette.</s><s>Creighton University, Omaha, USA: Henry T. Lynch, Carrie L. Snyder.</s><s>HCSC acknowledges Alicia Tosar and Paula Diaque for their technical assistance.</s><s>HEBCS would like to thank Dr. Kristiina Aittomäki, Taru A. Muranen, Drs.</s><s>Carl Blomqvist and Kirsimari Aaltonen and RNs Irja Erkkilä and Virpi Palola for their help with the HEBCS data and samples.</s><s>HEBON thanks the registration teams of the Comprehensive Cancer Centre Netherlands and Comprehensive Centre South (together the Netherlands Cancer Registry) and PALGA (Dutch Pathology Registry) for part of the data collection.</s><s>The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) consists of the following Collaborating Centers: Coordinating center: Netherlands Cancer Institute, Amsterdam, NL: M.A. Rookus, F.B.L. Hogervorst, F.E. van Leeuwen, S. Verhoef, M.K. Schmidt, N.S.</s><s>Russell, J.L. de Lange, R. Wijnands; Erasmus Medical Center, Rotterdam, NL: J.M. Collée, A.M.W. van den Ouweland, M.J. Hooning, C. Seynaeve, C.H.M. van Deurzen, I.M. Obdeijn; Leiden University Medical Center, NL: C. J. van Asperen, J.T. Wijnen, R.A.E.M. Tollenaar, P. Devilee, T.C.T.E.F.</s><s>van Cronenburg; Radboud University Nijmegen Medical Center, NL: C.M. Kets, A.R. Mensenkamp; University Medical Center Utrecht, NL: M.G.E.M. Ausems, R.B. van der Luijt, C.C. van der Pol; Amsterdam Medical Center, NL: C.M. Aalfs, T.A.M. van Os; VU University Medical Center, Amsterdam, NL: J.J.P. Gille, Q. Waisfisz, H.E.J. Meijers-Heijboer; University Hospital Maastricht, NL: E.B. Gómez-Garcia, M.J. Blok; University Medical Center Groningen, NL: J.C. Oosterwijk, A. H. van der Hout, M.J. Mourits, G.H. de Bock; The Netherlands Foundation for the detection of hereditary tumours, Leiden, NL: H.F. Vasen; The Netherlands Comprehensive Cancer Organization (IKNL): S. Siesling, J.Verloop; The Dutch Pathology Registry (PALGA): L.I.H. Overbeek.</s><s>HEBON thanks the registration teams of IKNL and PALGA for part of the data collection.</s><s>HRBCP wishes to thank Hong Kong Sanatorium and Hospital for their continued support.</s><s>HUNBOCS wishes to thank the Hungarian Breast and Ovarian Cancer Study Group members (Janos Papp, Tibor Vaszko, Aniko Bozsik, Timea Pocza, Judit Franko, Maria Balogh, Gabriella Domokos, Judit Ferenczi, Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary) and the clinicians and patients for their contributions to this study.</s><s>ICO wishes to thank the ICO Hereditary Cancer Program team led by Dr. Gabriel Capella.</s><s>INHERIT would like to thank Dr Martine Dumont, Martine Tranchant for sample management and skilful technical assistance.</s><s>J.S. is Chairholder of the Canada Research Chair in Oncogenetics.</s><s>J.S. and P.S. were part of the QC and Genotyping coordinating group of iCOGS (BCAC and CIMBA).</s><s>IPOBCS wishes to thank Drs. Ana Peixoto, Catarina Santos, Patrícia Rocha and Pedro Pinto for their skilful contribution to the study.</s><s>KCONFAB wishes to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (which has received funding from the NHMRC, the National Breast Cancer Foundation, Cancer Australia,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>BRCA1 or BRCA1/2 meta-analysis (Fig3), four of the eight candidate causal SNPs in BRCA1 mutation carriers are expressed single nucleotide polymorphism (eSNP) for the BNC2 gene in whole blood samples (Table1, data extracted from GTex Portal http://www.gtexportal.org/home/).</s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0158801 July 27, 2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="15">,252 (2,462 ovarian cancer cases) BRCA1 and 8,211 (631 ovarian cancer cases) BRCA2 mutation carriers. Following genotype imputation, ovarian cancer associations were assessed for 4,873 and 5,020 SNPs in BRCA1 and BRCA 2 mutation carriers respectively, within a retrospective cohort analytical framework. In BRCA1 mutation carriers one set of eight correlated candidate causal variants for ovarian cancer risk modification was identified (top SNP rs10124837, HR: 0.73, 95%CI: 0.68 to 0.79, p-value 2× 10−16). These variants were located up to 20 kb upstream of BNC2. In BRCA2 mutation carriers one region, up to 45 kb upstream of BNC2, and containing 100 correlated SNPs was identified as candidate causal (top SNP rs62543585, HR: 0.69, 95%CI: 0.59 to 0.80, p-value 1.0 × 10−6). The candidate causal in BRCA1 mutation carriers did not include the strongest associated variant at this locus in the general population. In sum, we identified a set of candidate causal variants in a region that encompasses the BNC2 transcription start site. The ovarian cancer association at 9p22.2 may be mediated by different variants in BRCA1 mutation carriers and in the general population. Thus, potentially different mechanisms may underlie ovarian cancer risk for mutation carriers and the general population.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>BCFR-AU acknowledges Maggie Angelakos, Judi Maskiell, Gillian Dite, Helen Tsimiklis.</s><s>BCFR-NY wishes to thank members and participants in the New York site of the Breast Cancer Family Registry for their contributions to the study.</s><s>BCFR-ON wishes to thank members and participants in the Ontario Familial Breast Cancer Registry for their contributions to the study.</s><s>BFBOCC-LT acknowledges Vilius Rudaitis, Laimonas Griškevičius.</s><s>BMBSA We wish to thank the families who contribute to the BMBSA study.</s><s>BRICOH wishes to thank Yuan Chun Ding and Linda Steele for their work in participant enrollment and biospecimen and data management.</s><s>CBCS thanks Bent Ejlertsen for the recruitment and genetic counseling of participants.</s><s>CNIO thanks Alicia Barroso, Rosario Alonso and Guillermo Pita for their assistance.</s><s>CONSIT TEAM acknowledges Daniela Zaffaroni of the Fondazione IRCCS Istituto Nazionale deti Tumori, Milano, Italy: Monica Barile and Irene Feroce of the Istituto Europeo di Oncologia, Milano, Italy; Alessandra Viel and Riccardo Dolcetti of the CRO Aviano National Cancer Institute, Aviano (PN), Italy; Laura Papi and Gabriele Capone of the University of Florence, Florence, Italy; Laura Ottini and Giuseppe Giannini of the "Sapienza" University, Rome, Italy; Antonella Savarese and Alyne Martayan of the Istituto Nazionale Tumori Regina Elena, Rome, Italy; Stefania Tommasi of the Istituto Nazionale Tumori "Giovanni Paolo II"-Bari, Italy.</s><s>GC-HBOC thanks Ms. JoEllen Weaver and Dr. Betsy Bove for their technical support.</s><s>GEMO wishes to pay a tribute to Olga M. Sinilnikova, who with Dominique Stoppa-Lyonnet initiated and coordinated GEMO until she sadly passed away on the 30th June 2014, and to thank all the GEMO collaborating groups for their contribution to this study.</s><s>GEMO</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jervis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Harrington</surname></persName>
		</author>
		<idno type="DOI">10.1136/jmedgenet-2013-102015</idno>
		<idno type="PMID">24277755</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="108" to="113" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pdp</forename><surname>Pharoah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Narod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Eyfjord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hopper</surname></persName>
		</author>
		<idno type="DOI">10.1086/375033</idno>
		<idno type="PMID">12677558</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1117" to="1130" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Hereditary ovarian cancer: beyond the usual suspects</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Pennington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Swisher</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2011.12.415</idno>
		<idno type="PMID">22264603</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecol Oncol</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="347" to="353" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ramus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kartsonaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Gayther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pdp</forename><surname>Pharoah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Sinilnikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beesley</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djq494</idno>
		<idno type="PMID">21169536</idno>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="105" to="116" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2</title>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ramus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gentry-Maharaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wozniak</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.424</idno>
		<idno type="PMID">19648919</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="996" to="1000" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The zinc-finger protein basonuclin 2 is required for proper mitotic arrest, prevention of premature meiotic initiation and meiotic progression in mouse male germ cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vanhoutteghem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Messiaen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hervé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Delhomme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-M</forename><surname>Petit</surname></persName>
		</author>
		<idno type="DOI">10.1242/dev.112888</idno>
		<idno type="PMID">25344072</idno>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="4298" to="4310" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Centlein mediates an interaction between C-Nap1 and Cep68 to maintain centrosome cohesion</title>
		<author>
			<persName><forename type="first">G</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1242/jcs.139451</idno>
		<idno type="PMID">24554434</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Sci</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1631" to="1639" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification and characterization of the novel centrosomal protein centlein</title>
		<author>
			<persName><forename type="first">K</forename><surname>Makino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Umeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Uezu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hiragami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ihn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2007.12.050</idno>
		<idno type="PMID">18086554</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="page" from="958" to="962" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)</title>
		<author>
			<persName><forename type="first">G</forename><surname>Chenevix-Trench</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Milne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Goldgar</surname></persName>
		</author>
		<idno type="DOI">10.1186/bcr1670</idno>
		<idno type="PMID">17466083</idno>
	</analytic>
	<monogr>
		<title level="j">Breast Cancer Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">104</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">iCOGS collection provides a collaborative model</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">G</forename><surname>Bahcall</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2592</idno>
		<idno type="PMID">23535721</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="343" to="343" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mcguffog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Olswold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pgen.1003212</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet. Public Library of Science</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e1003212</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gaudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vijai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kirchhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mcguffog</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pgen.1003173</idno>
		<idno type="PMID">23544012</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e1003173</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A new multipoint method for genome-wide association studies by imputation of genotypes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Marchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcvean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng2088</idno>
		<idno type="PMID">17572673</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Publishing Group</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="906" to="913" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>Nat Genet</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Goldgar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Andrieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chang-Claude</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brohet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Rookus</surname></persName>
		</author>
		<idno type="DOI">10.1002/gepi.20074</idno>
		<idno type="PMID">15880399</idno>
	</analytic>
	<monogr>
		<title level="j">Genet Epidemiol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptornegative breast cancer in the general population</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">S</forename><surname>Fredericksen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mcguffog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tarrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Sinilnikova</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.669</idno>
		<idno type="PMID">20852631</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="885" to="892" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<idno type="DOI">10.1002/gepi.21620</idno>
		<idno type="PMID">22714938</idno>
	</analytic>
	<monogr>
		<title level="j">Genet Epidemiol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="274" to="291" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Evaluating the power to discriminate between highly correlated SNPs in genetic association studies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Udler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<idno type="DOI">10.1002/gepi.20504</idno>
		<idno type="PMID">20583289</idno>
	</analytic>
	<monogr>
		<title level="j">Genet Epidemiol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="463" to="468" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coetzee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hazelett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lawrenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<idno type="DOI">10.1093/hmg/ddv101</idno>
		<idno type="PMID">25804953</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="3595" to="3607" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Pathology of ovarian cancers in BRCA1 and BRCA2 carriers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Lakhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Manek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Penault-Llorca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Flanagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arnout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Merrett</surname></persName>
		</author>
		<idno type="PMID">15073127</idno>
		<ptr target="http://www.ncbi.nlm.nih.gov/pubmed/15073127" />
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2473" to="2481" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coetzee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hazelett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lawrenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<idno type="DOI">10.1093/hmg/ddv101</idno>
		<idno type="PMID">25804953</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="3595" to="3607" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Identification of six new susceptibility loci for invasive epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ramus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beesley</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.3185</idno>
		<idno type="PMID">25581431</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="164" to="171" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mavaddat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Barrowdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Andrulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Domchek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Eccles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nevanlinna</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.EPI-11-0775</idno>
		<idno type="PMID">22144499</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="134" to="147" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
